Third Quarter Revenue Expansion and Performance Metrics
On November 9, 2026, health and wellness platform AOL reported that Hims & Hers Health, Inc. released its financial results for the third quarter ended September 30, 2026, highlighting a 49% year-over-year increase in total revenue. Total revenue reached $890.4 million for the period, compared to $599.0 million in the same period of 2025. The company attributed the acceleration to strong demand across both domestic markets and rapidly expanding international territories, marking the second consecutive quarter of accelerating revenue growth.
Domestic revenue within the United States grew 21% year-over-year to reach $657.1 million, up from $543.5 million in the third quarter of 2025. Meanwhile, international performance experienced a substantial surge, with rest-of-the-world revenue climbing more than 300% to $233.3 million, compared to $55.5 million in the prior year’s third quarter. Subscriber growth also continued upward, with the total number of subscribers reaching 2.78 million by the end of the period, representing a 13% increase from 2.47 million subscribers in the third quarter of 2025.
Monthly revenue per average subscriber rose to $105 during the third quarter of 2026, reflecting a 30% increase compared to $81 in the third quarter of 2025. For the first nine months of 2026, total revenue reached $2.25 billion, up 30% from $1.73 billion during the comparable period in 2025.
Profitability and Cash Flow Shifts
Despite significant top-line expansion, Hims & Hers reported a net loss of $33.0 million for the third quarter of 2026, contrasting with a net income of $15.8 million recorded in the third quarter of 2025. Gross margins also contracted, coming in at 57% for the quarter compared to 74% in the corresponding period of the previous year.
Adjusted EBITDA stood at $82.4 million for the third quarter of 2026, showing an increase from $78.4 million in the third quarter of 2025. Cash generation metrics showed net cash provided by operating activities at $65.4 million, down from $148.7 million in the prior-year period. Free cash flow dropped to $26.0 million for the quarter, compared to $79.4 million in the third quarter of 2025, as leadership paced marketing investments ahead of planned fourth-quarter expansions.
Chief Financial Officer Yemi Okupe noted that the company intentionally paced marketing spend ahead of several planned platform expansions slated for the fourth quarter. Leadership emphasized that these deliberate decisions are designed to support durable, multi-year growth heading into 2027 while maintaining a strong balance sheet to fund strategic objectives.
Strategic Outlook and Future Guidance
Looking ahead to the fourth quarter of 2026, Hims & Hers issued financial guidance projecting total revenue between $875 million and $895 million. The company expects adjusted EBITDA for the fourth quarter to range between $70 million and $90 million, implying an adjusted EBITDA margin of 8% to 10%.
For the full fiscal year 2026, management projected total revenue between $3.13 billion and $3.15 billion. Full-year adjusted EBITDA is anticipated to land between $257 million and $277 million, reflecting an expected margin of 8% to 9%. Co-founder and CEO Andrew Dudum emphasized that the company is investing in an AI-native customer experience and expanding medical specialties to solidify its market position and capture long-term consumer demand across global health and wellness sectors.